{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Three missense mutations for a-Syn, A30P, A53T and E46K have been known to be associated with rare autosomal dominant forms of familial PD.",
          "judgment": "Yes",
          "rationale": "The paper explicitly links these variants to familial Parkinson's disease (PD) as pathogenic mutations."
        },
        {
          "step_name": "Step 2: Assess assay relevance to disease mechanism",
          "extracted_paper_info": "The study uses SH-SY5Y cells overexpressing these variants and exposes them to rotenone/maneb to model PD pathogenesis.",
          "judgment": "Yes",
          "rationale": "The assay directly tests the role of α-Syn variants in PD-relevant cellular toxicity (neuronal death, aggregation)."
        },
        {
          "step_name": "Step 3a: Basic controls and replicates",
          "extracted_paper_info": "The study uses cells overexpressing wt, A30P, A53T, and E46K but does not explicitly state negative/positive control variants.",
          "judgment": "No",
          "rationale": "Lack of explicit benign/pathogenic control variant comparisons limits replicability."
        },
        {
          "step_name": "Step 3b: Assay validation",
          "extracted_paper_info": "The paper references prior studies on α-Syn's role in PD and uses established cell models.",
          "judgment": "Yes",
          "rationale": "The assay is validated by prior research and standard cell models for PD mechanistic studies."
        },
        {
          "step_name": "Step 4b: Control variant counts",
          "extracted_paper_info": "The study uses four variants (wt, A30P, A53T, E46K) but does not explicitly report benign/pathogenic controls.",
          "judgment": "10 or less",
          "rationale": "Only four variants are tested, with no explicit benign/pathogenic controls reported."
        }
      ],
      "strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Three missense mutations for a-Syn, A30P, A53T and E46K have been known to be associated with rare autosomal dominant forms of familial PD.",
          "judgment": "Yes",
          "rationale": "The paper explicitly links these variants to familial Parkinson's disease (PD) as pathogenic mutations."
        },
        {
          "step_name": "Step 2: Assess assay relevance to disease mechanism",
          "extracted_paper_info": "The study uses SH-SY5Y cells overexpressing these variants and exposes them to rotenone/maneb to model PD pathogenesis.",
          "judgment": "Yes",
          "rationale": "The assay directly tests the role of α-Syn variants in PD-relevant cellular toxicity (neuronal death, aggregation)."
        },
        {
          "step_name": "Step 3a: Basic controls and replicates",
          "extracted_paper_info": "The study uses cells overexpressing wt, A30P, A53T, and E46K but does not explicitly state negative/positive control variants.",
          "judgment": "No",
          "rationale": "Lack of explicit benign/pathogenic control variant comparisons limits replicability."
        },
        {
          "step_name": "Step 3b: Assay validation",
          "extracted_paper_info": "The paper references prior studies on α-Syn's role in PD and uses established cell models.",
          "judgment": "Yes",
          "rationale": "The assay is validated by prior research and standard cell models for PD mechanistic studies."
        },
        {
          "step_name": "Step 4b: Control variant counts",
          "extracted_paper_info": "The study uses four variants (wt, A30P, A53T, E46K) but does not explicitly report benign/pathogenic controls.",
          "judgment": "10 or less",
          "rationale": "Only four variants are tested, with no explicit benign/pathogenic controls reported."
        }
      ],
      "strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "SNCA E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Three missense mutations for a-Syn, A30P, A53T and E46K have been known to be associated with rare autosomal dominant forms of familial PD.",
          "judgment": "Yes",
          "rationale": "The paper explicitly links these variants to familial Parkinson's disease (PD) as pathogenic mutations."
        },
        {
          "step_name": "Step 2: Assess assay relevance to disease mechanism",
          "extracted_paper_info": "The study uses SH-SY5Y cells overexpressing these variants and exposes them to rotenone/maneb to model PD pathogenesis.",
          "judgment": "Yes",
          "rationale": "The assay directly tests the role of α-Syn variants in PD-relevant cellular toxicity (neuronal death, aggregation)."
        },
        {
          "step_name": "Step 3a: Basic controls and replicates",
          "extracted_paper_info": "The study uses cells overexpressing wt, A30P, A53T, and E46K but does not explicitly state negative/positive control variants.",
          "judgment": "No",
          "rationale": "Lack of explicit benign/pathogenic control variant comparisons limits replicability."
        },
        {
          "step_name": "Step 3b: Assay validation",
          "extracted_paper_info": "The paper references prior studies on α-Syn's role in PD and uses established cell models.",
          "judgment": "Yes",
          "rationale": "The assay is validated by prior research and standard cell models for PD mechanistic studies."
        },
        {
          "step_name": "Step 4b: Control variant counts",
          "extracted_paper_info": "The study uses four variants (wt, A30P, A53T, E46K) but does not explicitly report benign/pathogenic controls.",
          "judgment": "10 or less",
          "rationale": "Only four variants are tested, with no explicit benign/pathogenic controls reported."
        }
      ],
      "strength": "PS3_supporting"
    }
  ]
}